deltatrials
Terminated PHASE1 INTERVENTIONAL 1-arm NCT01744171

Vaccine Therapy in Treating Patients With Advanced Stage III-IV Melanoma

A Phase I Trial of a Recombinant Human hsp110-gp100 Chaperone Complex Vaccine for Advanced Stage IIIB/C or IV Melanoma

Sponsor: Roswell Park Cancer Institute

Conditions Recurrent Melanoma Stage IIIB Skin Melanoma Stage IIIC Skin Melanoma Stage IV Skin Melanoma
Interventions Laboratory Biomarker Analysis Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine
Updated 20 times since 2017 Last updated: Jul 20, 2022 Started: Mar 26, 2013 Primary completion: Jun 11, 2018 Completion: Jun 11, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Study was Suspended since 2018; PI decided to terminate.

Other terminated trials from Roswell Park Cancer Institute

See all terminations from Roswell Park Cancer Institute

Other Recurrent Melanoma trials with similar outcome

Browse all Recurrent Melanoma trials

A PHASE1 clinical study on Recurrent Melanoma and Stage IIIB Skin Melanoma, this trial is terminated or withdrawn. The trial is conducted by Roswell Park Cancer Institute and has accumulated 20 data snapshots since 2013. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Mar 2017 · 28 days · monthly snapshot~Mar 2017 – ~Jun 2018 · 15 months · monthly snapshot~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshot~Sep 2018 – ~Oct 2018 · 30 days · monthly snapshot~Oct 2018 – ~Dec 2018 · 2 months · monthly snapshot~Dec 2018 – ~Jan 2019 · 31 days · monthly snapshot~Jan 2019 – ~Mar 2019 · 59 days · monthly snapshot~Mar 2019 – ~Apr 2019 · 31 days · monthly snapshot~Apr 2019 – ~Jul 2019 · 3 months · monthly snapshot~Jul 2019 – ~Aug 2019 · 31 days · monthly snapshot~Aug 2019 – ~Oct 2019 · 2 months · monthly snapshot~Oct 2019 – ~Dec 2019 · 2 months · monthly snapshot~Dec 2019 – ~Feb 2020 · 2 months · monthly snapshot~Feb 2020 – ~Jun 2020 · 4 months · monthly snapshot~Jun 2020 – ~Jan 2021 · 7 months · monthly snapshot~Jan 2021 – ~Sep 2022 · 20 months · monthly snapshot~Sep 2022 – ~Jul 2024 · 22 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 24 months · monthly snapshot

Change History

20 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE1

  3. Sep 2022 — Jul 2024 [monthly]

    Terminated PHASE1

  4. Jan 2021 — Sep 2022 [monthly]

    Terminated PHASE1

  5. Jun 2020 — Jan 2021 [monthly]

    Terminated PHASE1

    Status: Suspended → Terminated

▶ Show 15 earlier versions

  1. Feb 2020 — Jun 2020 [monthly]

    Suspended PHASE1

  2. Dec 2019 — Feb 2020 [monthly]

    Suspended PHASE1

  3. Oct 2019 — Dec 2019 [monthly]

    Suspended PHASE1

  4. Aug 2019 — Oct 2019 [monthly]

    Suspended PHASE1

  5. Jul 2019 — Aug 2019 [monthly]

    Suspended PHASE1

    Status: Active Not Recruiting → Suspended

  6. Apr 2019 — Jul 2019 [monthly]

    Active Not Recruiting PHASE1

    Status: Recruiting → Active Not Recruiting

  7. Mar 2019 — Apr 2019 [monthly]

    Recruiting PHASE1

  8. Jan 2019 — Mar 2019 [monthly]

    Recruiting PHASE1

  9. Dec 2018 — Jan 2019 [monthly]

    Recruiting PHASE1

  10. Oct 2018 — Dec 2018 [monthly]

    Recruiting PHASE1

  11. Sep 2018 — Oct 2018 [monthly]

    Recruiting PHASE1

  12. Jun 2018 — Sep 2018 [monthly]

    Recruiting PHASE1

  13. Mar 2017 — Jun 2018 [monthly]

    Recruiting PHASE1

  14. Feb 2017 — Mar 2017 [monthly]

    Recruiting PHASE1

  15. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE1

    First recorded

Mar 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Roswell Park Cancer Institute
Data source: Roswell Park Cancer Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations